Vidac has built a portfolio of product candidates that address significant unmet medical needs. The value proposition of these novel drugs stems from a unique mechanism of action that offers dermatologists, oncologists and patients both efficacy as well as tolerability.
First-in-Class Portfolio in Dermatology and Oncology
